Rare condition

Sheehan syndrome

ORPHA:91355 ↗Malformation syndrome

0

studies recruiting now

as of 7 Sept 2026

1

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No recruiting trial found right now.

1 study is registered for Sheehan syndrome, but none was recruiting as of 7 Sept 2026. Here is what is still worth doing.

Keep watching

Get an email when a new Sheehan syndrome study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Sheehan syndrome

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

1 approved treatment and 9 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Mogamulizumab (Poteligeo)
Phase 3Zanolimumab (Humax-cd4)
Phase 2Methoxsalen (8-mop)
Phase 2Pembrolizumab (Keytruda)
Phase 2Doxycycline (Doxirobe)
Phase 2Nelarabine (Arranon)
Phase 2Alemtuzumab (Campath mabcampath)
Phase 2Atezolizumab (Atezolizumab component of tecentriq hybreza)
Phase 1Ciaftalan

+ 1 more in development

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).